Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?

Basit Öğe Kaydı
dc.contributor.authorInanc, Nevsun
dc.contributor.authorOzen, Gulsen
dc.contributor.authorYalcinkaya, Yasemin
dc.contributor.authorDalkilic, Ediz
dc.contributor.authorKoca, Suleyman Serdar
dc.contributor.authorCan, Gercek
dc.contributor.authorOnen, Fatos
dc.date.accessioned2026-08-12T18:12:53Z
dc.date.issued2017
dc.departmentFırat Üniversitesi
dc.description81st Annual Meeting of the American-College-of-Rheumatology (ACR) / Association-of-Rheumatology-Health-Professionals (ARHP) -- NOV 03-08, 2017 -- San Diego, CA
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipAmer Coll Rheumatol,Assoc Rheumatol Hlth Profess
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.urihttps://hdl.handle.net/11508/64103
dc.identifier.volume69
dc.identifier.wosWOS:000411824100541
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofArthritis & Rheumatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleIs There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu